biologic

This page covers all biologic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting tumor necrosis factor, IL-23.

Targets

tumor necrosis factor · IL-23

Marketed (1)

• tumor necrosis factor inhibitors (TNFi) · Pfizer · Oncology

Phase 2 pipeline (1)

• Anti-IL23 · Prof. Dr. Stephan Weidinger · Immunology
  IL-23 inhibitor